naphthalimides has been researched along with Autoimmune Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abboud, HE; Cavaglieri, RC; Choudhury, GG; Feliers, D; Kasinath, BS; Lee, HJ; Mariappan, MM; Sataranatarajan, K | 1 |
1 other study(ies) available for naphthalimides and Autoimmune Diabetes
| Article | Year |
|---|---|
Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells.
Topics: Adaptor Proteins, Signal Transducing; Air Pollutants; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Benzimidazoles; Calcium-Calmodulin-Dependent Protein Kinases; Carbon-Oxygen Lyases; Carrier Proteins; Cell Cycle Proteins; Cells, Cultured; Cystathionine beta-Synthase; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Eukaryotic Initiation Factors; Extracellular Matrix Proteins; Glucose; Hydrogen Sulfide; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Multiprotein Complexes; Naphthalimides; Peptide Chain Elongation, Translational; Peptide Chain Initiation, Translational; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Proteins; Rats; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; Sweetening Agents; TOR Serine-Threonine Kinases | 2012 |